04:11 AM EST, 01/21/2026 (MT Newswires) -- Anteris Technologies Global ( AVR ) said late Tuesday it priced a public offering of about 34.8 million common shares at $5.75 per share for expected gross proceeds of roughly $200 million.

Underwriters have been granted a 30-day option to purchase up to an additional 5.2 million common shares.

The offering is set to close Thursday.

Anteris also signed a deal Tuesday to sell to Medtronic (MDT) up to $90 million of its common shares in a private placement.

Net proceeds from the offering, including current cash and cash equivalents, as well as the proceeds from the Medtronic deal, will be used to support the company's growth and clinical strategy.

A part of the proceeds will also be used to finance current research and development for v2vmedtech, with the balance allocated to working capital and other general corporate requirements, the company said.

Shares of Anteris rose more than 25% in recent premarket activity Wednesday.

Price: 7.23, Change: +1.48, Percent Change: +25.74